Skye Bioscience, Inc. Common Stock

Skye Bioscience, Inc. Common Stock (SKYE) SEC filings

Skye Bioscience, Inc. Common Stock (SKYE) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Net income was -$12.8M. SKYE currently screens at market cap $25.0M. The SKYE filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Skye Bioscience, Inc. Common Stock said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

5

8-K

0

Form 4

Recent filings

8-K1.013.029.01

8-K exhibit

EDGAR
8-K3.03

8-K exhibit

EDGAR
8-K

8-K exhibit

EDGAR
8-K1.013.023.03

8-K exhibit

EDGAR
8-K8.01

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all SKYE filings.

Frequently asked questions

What did SKYE just say?

SKYE cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are SKYE SEC filings?

5 cached filings are on this page. EDGAR remains the official archive (CIK 0001516551).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.